Changes in bone mass and serum markers of bone metabolism after parathyroidectomy

Surgery

Volumn 122, Issue 5, 1997, Pages 882-887

  Thorsen, Kim ^a   Kristoffersson, Anders O ^a,b   Lorentzon, Ronny P ^a  

^a Univ Hospital of Northern Sweden ^*

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; OSTEOCALCIN; PROCOLLAGEN;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MASS; BONE METABOLISM; CLINICAL ARTICLE; COLLAGEN METABOLISM; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; PARATHYROIDECTOMY; POSTMENOPAUSE; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL;

EID: 0030686513     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(97)90328-7     Document Type: Article

References (47)

1. Albright F, Aub JC, Bauer W. Hyperparathyroidism: a common and polymorphic condition as illustrated by seventeen cases from one clinic. JAMA 1934;102:1276-87.
2. Kristoffersson A, Dahlgren K, Granstrand B, Järhult J. Primary hyperparathyroidism in northern Sweden. Surg Gynecol Obstet 1987;164:1-5.
3. Heath H III, Hodgson SF, Kennedy MA. Primary hyperparathyroidism: incidence, morbidity and potential economic impact in a community. N Engl J Med 1980;302:189-93.
4. Breslau NA, Pak CYC. Asymptomatic primary hyperparathyroidism. In: Coe FL, Favus MJ, editors. Disorders of bone and mineral metabolism. New York: Raven Press; 1992. p 523-38.
5. Concensus Development Conference Panel. Diagnosis and management of asymptomatic primary hyperparathyroidism: concensus development conference statement. Ann Intern Med 1991;114:593-7.
6. Garton M, Martin J, Stewart A, Krukowski Z, Matheson N, Robins S, et al. Changes in bone mass and metabolism after surgery for primary hyperparathyroidism. Clin Endocrinol 1995;42:493-500.
7. Clyde JW, Wittert GA, Gilchrist NL, Turner JG, Donald RA, Espiner EA. The effect of parathyroidectomy on bone mineral density in primary hyperparathyroidism. N Z Med J 1992;105:71-2.
8. Silverberg SJ, Gartenberg F, Jacobs TP, Shane E, Siris E, Staron RB, et al. Longitudinal measurements of bone density and biochemical indices in untreated primary hyperparathyroidism. J Clin Endocrinol Metab 1995;80:723-8.
9. Grey AB, Evans MC, Stapleton JP, Reid IR. Body weight and bone mineral density in postmenopausal women with primary hyperparathyroidism. Ann Intern Med 1994;121:745-9.
10. Kenny AM, MacGillivray DC, Pilbeam CC, Crombie HD, Raisz LG. Fracture incidence in postmenopausal women with primary hyperparathyroidism. Surgery 1995;118:109-14.
11. Melton LJ III, Atkinson EJ, O'Fallon M, Heath H III. Risk of age-related fractures in patients with primary hyperparathyroidism. Arch Intern Med 1992;152:2269-73.
12. Larsson K, Lindh E, Lind L, Persson I, Ljunghall S. Increased fracture risk in hypercalcemia: bone mineral content measured in hyperparathyroidism. Acta Orthop Scand 1989;60:268-70.
13. Wishart J, Horowitz M, Need A, Nordin BEC. Relationship between forearm and vertebral mineral density in postmenopausal women with primary hyperparathyroidism. Arch Intern Med 1990;150:1329-31.
14. Larsson K, Ljunghall S, Krusemo UB, Nœssén T, Lindh E, Persson I. The risk of hip fractures in patients with primary hyperparathyroidism: a population-based cohort study with a follow-up of 19 years. J Intern Med 1993;234:585-93.
15. Kochersberger G, Buckley NJ, Leight GS, Martinez S, Studenski S, Vogler J, et al. What is the clinical significance of bone loss in primary hyperparathyroidism? Arch Intern Med 1987;147:1951-3.
16. Wilson RJ, Rao DS, Ellis B, Kleerekoper M, Parfitt AM. Mild asymptomatic primary hyperparathyroidism is not a risk factor for vertebral fractures. Ann Intern Med 1988;109:959-62.
17. Parisien M, Cosman F, Mellish RWE, Schnitzer M, Nieves J, Silverberg SJ, et al. Bone structure in postmenopausal hyperparathyroid, osteoporotic, and normal women. J Bone Miner Res 1995;10:1393-9.
18. Melkko J, Niemi S, Risteli L, Risteli J. Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem 1990;36:1328-32.
19. Risteli J, Melkko J, Niemi S, Risteli L. Use of a marker of collagen formation in osteoporosis studies. Calcif Tissue Int 1991;49:S24-5.
20. Eriksen EF, Charles P, Meisen F, Mosekilde L, Risteli L, Risteli J. Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry. J Bone Miner Res 1993;8:127-32.
21. Charles P, Mosekilde L, Risteli L, Risteli J, Eriksen EF. Assessment of bone remodeling using biochemical indicators of type I collagen synthesis and degradation: relation to calcium kinetics. Bone Miner 1994;24:81-94.
22. Coen G, Mazzaferro S, De Antoni E, Chicca S, DiSanza P, Onorato L, et al. Procollagen type 1 C-terminal extension peptide serum levels following parathyroidectomy in hyperparathyroid patients. Am J Nephrol 1994;14:106-12.
23. Minisola S, Romagnoli E, Scarnecchia L, Rosso R, Pacitti MT, Scarda A, et al. Serum carboxy-terminal propeptide of human type I procollagen in patients with primary hyperparathyroidism: studies in basal conditions and after parathyroid surgery. Eur J Endocrinol 1994;130:587-91.
24. Genant HK, Heck LL, Lanzl LH, Rossmann K, Van der Horst J, Palyon E. Primary hyperparathyroidism: a comprehensive study of clinical, biochemical and radiografic manifestations. Radiology 1973;109:513-24.
25. Silverberg SJ, Shane E, De la Cruz L, Dempster DW, Feldman F, Seldin D, et al. Skeletal disease in primary hyperparathyroidism. J Bone Miner Res 1989;4:283-91.
26. Parisien M, Silverberg SJ, Shane E, De la Cruz L, Lindsay R, Bilezikian JP, et al. The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure. J Clin Endocrinol Metab 1990;70:930-8.
27. Vogel M, Hahn M, Delling G. Trabecular bone structure in patients with primary hyperparathyroidism. Virchows Archiv 1995;426:127-34.
28. Brockstedt H, Christiansen P, Mosekilde L, Melsen F. Reconstruction of cortical bone remodeling in untreated primary hyperparathyroidism and following surgery. Bone 1995;16:109-17.
29. Casez JP, Troendle A, Lippuner K, Jaeger P. Bone mineral density at distal tibia using dual-energy X-ray absorptiometry in normal women and in patients with vertebral osteoporosis or primary hyperparathyroidism. J Bone Miner Res 1994;9:1851-7.
30. McDermott MT, Perloff JJ, Kidd GS. Effects of mild asymptomatic primary hyperparathyroidism on bone mass in women with and without estrogen replacement therapy. J Bone Miner Res 1994;9:509-14.
31. Minisola S, Scarnecchia L, Scarda A, Bigi F, Tabolli S, Valtorta C, et al. Serum osteocalcin in primary hyperparathyroidism: short-term effect of surgery. Miner Electrolyte Metab 1988;14:201-7.
32. Minisola S, Rosso R, Romagnoli E, Pacitti MT, Scarnecchia L, Carnevale V, et al. Trabecular bone mineral density in primary hyperparathyroidism: relationship to clinical presentation and biomarkers of skeletal turnover. Bone Miner 1993;20:113-23.
33. Silverberg SJ, Gartenberg F, Jacobs TP, Shane E, Siris E, Staron RB, et al. Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism. J Clin Endocrinol Metab 1995;80:729-34.
34. Abugassa S, Nordenström J, Eriksson S, Möllerström G, Alveryd A. Skeletal remineralization after surgery for primary and secondary hyperparathyroidism. Surgery 1990;107:128-33.
35. Martin P, Bergmann P, Gillet C, Fuss M, Corvilain J, Van Geertruyden J. Long-term irreversibility of bone loss after surgery for primary hyperparathyroidism. Arch Intern Med 1990;150:1495-7.
36. Sartoris DJ, Sommer FG, Kosek J, Gies A, Carter D. Dual-energy projection radiography in the evaluation of femoral neck strength, density, and mineralization. Invest Radiol 1985;20:476-85.
37. Minisola S, Carnevale V, Pacitti MT, Romagnoli E, Scarnecchia L, Rosso R, et al. Serum osteocalcin in metabolic bone diseases: what is its real significance? J Endocrinol Invest 1993;16:277-9.
38. Charles P, Hasling C, Risteli J, Risteli L, Mosekilde L, Eriksen EF. Assessment of bone formation by biochemical markers in metabolic bone disease: separation between osteoblastic activity at the cell and tissue level. Calcif Tissue Int 1992:51:406-11.
39. Pfeilschifter J, Siegrist E, Wüster C, Blind E, Ziegler R. Serum levels of intact parathyroid hormone and alkaline phosphatase correlate with cortical and trabecular bone loss in primary hyperparathyroidism. Acta Endocrinol 1992;127:319-23.
40. Pietschmann P, Niederle B, Anvari A, Woloszczuk W. Serum osteocalcin levels in primary hyperparathyroidism. Klin Wochenschr 1991;69:351-3.
41. Štêpán JJ, Šilenková-Málková E, Havránek T, Formánková J, Zichová M, Lachmanová J, et al. Relationship of plasma tartrate resistant acid phosphatase to the bone isoenzyme of serum alkaline phophatase in hyperparathyroidism. Clin Chim Acta 1983;133:189-200.
42. Simon LE, Slovik DM, Neer RM, Krane SM. Changes in serum levels of type I and III procollagen extension peptides during infusion of human parathyroid hormone frag-ment (1-34). J Bone Miner Res 1988;3:241-6.
43. Brahm H, Ljunggren Ö, Larson K, Lindh E, Ljunghall S. Effects of infusion of parathyroid hormone and primary hyperparathyroidism on formation and breakdown of type I collagen. Calcif Tissue 1994;55:412-6.
44. Thorsen K, Kristoffersson A, Lorentzon R. The effect of brisk walking on markers of bone and calcium metabolism in postmenopausal women. Calcif Tissue Int 1996;58:221-5.
45. Seibel MJ, Gartenberg F, Silverberg SJ, Ratcliffe A, Robins SP, Bilezikian JP. Urinary hydroxypyridinium cross-links of collagen in primary hyperparathyroidism. J Clin Endocrinol Metab 1992;74:481-6.
46. Frevert EU, Biester A, Müller MJ, Schmidt-Gayk H, Mühlen A von zur, Brabant G. Markers of bone metabolism during short-term administration of thyroxine in healthy volunteers. Eur J Endocrinol 1994;131:145-9.
47. Salvesen H, Piehl-Aulin K, Ljunghall S. Change in levels of the carboxyterminal propeptide of type I procollagen, the carboxyterminal cross-linked telopeptide of type I collagen and osteocalcin in response to exercise in well-trained men and women. Scand J Med Sci Sports 1994;4:186-90.